This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Pueraria mirifica (White Kwao Krua) is a Thai medicinal plant rich in phytoestrogens used primarily to alleviate menopausal symptoms [PMID:31377923, PMID:29409850].
Background
Pueraria mirifica, also known as White Kwao Krua or white kudzu, is a medicinal botanical indigenous to Southeast Asia, specifically Thailand and Myanmar [PMID:42328653]. It is characterized by tuberous roots containing estrogen-like substances [PMID:21938956].
Traditional uses
It has been used in Thai traditional medicine and folklore for nearly one hundred years as a rejuvenating therapy for aged women and men, specifically for estrogen-related conditions and age-associated functional decline [PMID:31377923, PMID:22460444, PMID:42328653].
Active compounds
The plant contains phytoestrogens, including isoflavonoids (such as puerarin, daidzin, daidzein, and genistin) and chromenes (specifically miroestrol, deoxymiroestrol, isomiroestrol, and (+)-7-O-Methylisomiroestrol) [PMID:36218384, PMID:36950953, PMID:28152387, PMID:32077760, PMID:25036114]. Kwakhurin is also identified as a unique marker compound [PMID:30585546, PMID:33020994].
Mechanism of action
Pueraria mirifica exhibits estrogenic activity via its phytoestrogens [PMID:30585546]. Puerarin may improve Metabolic dysfunction-associated steatotic liver disease (MASLD) by remodeling the intestinal microenvironment to promote mitochondrial fusion and autophagy [PMID:40121054]. Ethyl acetate extracts have been shown to dose-dependently reduce NO production and iNOS expression in microglial cells by attenuating IRF-1 induction [PMID:36232220].
Clinical evidence
Evidence AVasomotor symptoms (hot flushes, night sweats)
A Phase II study showed a decrease in the modified Greene climacteric scale for patients receiving 50 mg or 100 mg daily over six months [PMID:14971532]. A systematic review of eight studies indicated climacteric scores were reduced by approximately 50% compared to baseline [PMID:29409850].
Evidence BVaginal health in postmenopausal women
Pueraria mirifica (20, 30, or 50 mg) decreased vaginal dryness symptoms and increased the vaginal maturation index after 24 weeks [PMID:17415017]. A 6% vaginal gel significantly decreased the pulsatility index (PI) and resistance index (RI) of vaginal arteries compared to placebo at 12 weeks [PMID:35550707].
Evidence DHypercholesterolemia (Rabbit Model)
Daily intake of 100 mg/kg/day of White kwao krua alleviated LDL oxidative susceptibility and plasma LDL levels and improved vasculature [PMID:32953566].
Evidence DBone Health
In vitro and animal studies suggest puerarin inhibits bone resorption and improves bone structure, potentially reducing osteoporosis risk [PMID:34994179].
Safety & adverse effects
In a Phase I study, no major laboratory abnormalities were noted except for one case of transiently increased creatinine and one case of increased blood urea nitrogen [PMID:17710964]. One study reported no significant difference in adverse effects between the herb and placebo groups [PMID:17415017]. However, side effects of dietary supplements have been reported by the Ministry of Health, Labour and Welfare, Japan [PMID:32434998].
Dosage & administration
Clinical studies have utilized oral capsules at doses of 20, 30, 50, or 100 mg once daily [PMID:17415017, PMID:14971532]. A 6% vaginal gel has also been used [PMID:35550707]. No PubMed data available. Consult a healthcare provider.
Evidence summary
Evidence is strongest (Level A/B) for the alleviation of menopausal vasomotor symptoms and improvement of vaginal health. Preclinical evidence (Level D) suggests potential benefits for lipid profiles, bone health, and anti-inflammatory effects in microglia.
PubMed sources
1.PMID: 31377923 (2020) — Evaluation of white Kwao Krua (Pueraria candollei Grah. ex Benth.) products sold in Thailand by molecular, chemical, and microscopic analyses. · Journal of natural medicines
2.PMID: 36218384 (2023) — Daidzein Hydroxylation by CYP81E63 Is Involved in the Biosynthesis of Miroestrol in Pueraria mirifica. · Plant & cell physiology
3.PMID: 15234761 (2004) — The differential anti-proliferation effect of white (Pueraria mirifica), red (Butea superba), and black (Mucuna collettii) Kwao Krua plants on the growth of MCF-7 cells. · Journal of ethnopharmacology
4.PMID: 32953566 (2020) — Daily White kwao krua dietary supplement alleviates LDL oxidative susceptibility, plasma LDL level and improves vasculature in a hypercholesterolemia rabbit model. · Journal of traditional and complementary medicine
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
— Immunochromatographic assay for miroestrol and deoxymiroestrol, its cross-reactivity, and application in Pueraria mirifica (white Kwao Krua) analysis.
· Phytochemical analysis : PCA
6.PMID: 37920497 (2023) — Ultrafine comminution-assisted ultrasonic-microwave synergistic extraction of Pueraria mirifica (Kudzu flower and root) flavonoids. · Heliyon
7.PMID: 28152387 (2017) — Development of an enzyme-linked immunosorbent assay for the detection of isomiroestrol, an identical marker, in White Kwao Krua using a monoclonal antibody. · Journal of pharmaceutical and biomedical analysis
8.PMID: 14971532 (2004) — Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study. · Journal of the Medical Association of Thailand = Chotmaihet thangphaet
9.PMID: 23470445 (2013) — Characteristic chemical components of the essential oil from white kwao krua (Pueraria mirifica). · Journal of oleo science
10.PMID: 21938956 (2011) — White Kwao Krua variety classification by botanical characteristics and ISSR-Touchdown PCR technique. · Genetika
11.PMID: 28573485 (2017) — A lateral flow colloidal gold-based immunoassay for rapid detection of miroestrol in samples of White Kwao Krua, a phytoestrogen-rich plant. · Journal of natural medicines
12.PMID: 34994179 (2021) — Puerarin-an isoflavone with beneficial effects on bone health. · Frontiers in bioscience (Landmark edition)
13.PMID: 35550707 (2022) — Effects of Pueraria mirifica on vaginal artery vascularization in postmenopausal women with genitourinary syndrome of menopause. · Maturitas
14.PMID: 32434998 (2020) — Facile Synthesis of Kwakhurin, a Marker Compound of Pueraria mirifica and Its Quantitative NMR Analysis for Standardization as a Reagent. · Chemical & pharmaceutical bulletin
15.PMID: 42328653 (2026) — Pueraria mirifica: a critical review of the ethnobotany, phytochemistry, pharmacology and challenges in standardization and safety. · Frontiers in pharmacology
16.PMID: 17415017 (2007) — Effect of Pueraria mirifica on vaginal health. · Menopause (New York, N.Y.)
17.PMID: 32077760 (2021) — (+)-7-O-Methylisomiroestrol, a new chromene phytoestrogen from the Pueraria candollei var. mirifica root. · Natural product research
18.PMID: 36232220 (2022) — Inhibition of LPS-Induced Microglial Activation by the Ethyl Acetate Extract of Pueraria mirifica. · International journal of environmental research and public health
19.PMID: 25036114 (2014) — Pueraria mirifica leaves, an alternative potential isoflavonoid source. · Bioscience, biotechnology, and biochemistry
20.PMID: 29409850 (2018) — Efficacy and safety of Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham for menopausal women: A systematic review of clinical trials and the way forward. · Journal of ethnopharmacology
21.PMID: 30585546 (2018) — A Recombinant Fab Antibody Against Kwakhurin as a Tool for Sensitive Indirect Competitive ELISA. · Current pharmaceutical biotechnology
22.PMID: 22460444 (2012) — Medical applications of phytoestrogens from the Thai herb Pueraria mirifica. · Frontiers of medicine
23.PMID: 22708703 (2013) — Quantitative analysis of miroestrol and kwakhurin for standardisation of Thai miracle herb 'Kwao Keur' (Pueraria mirifica) and establishment of simple isolation procedure for highly estrogenic miroestrol and deoxymiroestrol. · Natural product research
24.PMID: 33020994 (2021) — Immunochromatographic assay for the detection of kwakhurin and its application for the identification of Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham. · Phytochemical analysis : PCA
25.PMID: 40121054 (2025) — Puerarin improves MASLD by remodeling intestinal microenvironment to promote mitochondrial fusion and autophagy. · Journal of pharmacological sciences
26.PMID: 10691701 (2000) — Identification of deoxymiroestrol as the actual rejuvenating principle of "Kwao Keur", Pueraria mirifica. The known miroestrol may be an artifact. · Journal of natural products
27.PMID: 26689919 (2016) — Preparation and application of a monoclonal antibody against the isoflavone glycoside daidzin using a mannich reaction-derived hapten conjugate. · Phytochemical analysis : PCA
28.PMID: 31878891 (2019) — Transcriptome analysis of Pueraria candollei var. mirifica for gene discovery in the biosyntheses of isoflavones and miroestrol. · BMC plant biology
29.PMID: 17710964 (2007) — Challenges in the conduct of Thai herbal scientific study: efficacy and safety of phytoestrogen, pueraria mirifica (Kwao Keur Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women. · Journal of the Medical Association of Thailand = Chotmaihet thangphaet